Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · LXCHEM

LXCHEM

CommoditiesChemicals & Petrochemicals₹4185 cr market cap
₹153.85 ▲ +2.02% today As of 19 Nov 2026
52-week low ₹108.1152-week high ₹200.51

-24.8% from the 52-week high · +39.5% above the low

Laxmi Organic Industries Ltd. engages in the manufacture of acetyl and specialty intermediates. The company is headquartered in Mumbai, Maharashtra and currently employs 874 full-time employees. The company went IPO on 2021-03-25. The firm manufactures ethyl acetate, acetic acid and diketene derivative products (DDP). Its business segments include Acetyl Intermediates and Speciality Intermediates. The Acetyl Intermediates segment produces a range of acetyl products, including Bulk Solvents and Aldehydes. The firm manufactures a range of Acetyl products, including bulk solvents and aldehydes. Its acetyl products have applications in diverse industries, such as pharmaceutical formulations, printing inks, adhesives, coatings. The company is also a manufacturer of Speciality Intermediates, such as Ketene & Diketene derivatives, including Esters, Amides and Arylides. Its Speciality Intermediates has applications in pharmaceuticals, synthesis and manufacturing of agrochemicals, pigments, and others. The company also offers custom synthesis of Diketene Derivative Chemicals and Crop and Life Science Intermediates.

The short version. LXCHEM reported revenue of ₹1,083 crore for Sep 2026, up 54.7% from a year earlier. Net profit was ₹57 crore (up 418.2% year on year). Return on equity was 4.0% in Mar 2026. Promoter holding was 69.16% in Sep 2026, down 0.22 points over 8 quarters.

1 · The price

How has the stock traded?

LXCHEM trades 24.8% below its 52-week high and 39.5% above its 52-week low.

Change over period: —

1M-11.9%
3M-13.5%
6M-4.8%
1Y-18.2%

2 · The business

Is it growing?

Sales, year on year+54.7%

Sep 2026 revenue of ₹1,083 cr.

Profit, year on year+418.2%

Sep 2026 net profit of ₹57 cr.

Net margin5.3%

3.7 pts higher than a year earlier.

3-year growth-14.0% profit

Revenue compounded at 0.6% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1083968735719700693710786
Net profit5768222511212229
Net margin %5.37.02.93.51.63.13.13.7
EPS (₹)2.052.440.780.920.40.770.791.06

Annual

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue284729852865279730841768
Net profit79114121125256127
Net margin %2.83.84.24.58.37.2
EPS (₹)2.864.14.374.79.724.82

3 · The quality

How well does it turn capital into profit?

Return on equity was 4.0% in Mar 2026; debt to equity is 0.27.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %4.05.96.78.8
Return on capital %4.49.19.211.6
EBITDA margin %6.510.19.89.1
Net margin %2.83.84.24.4

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR0.6%10.1%
Profit CAGR-14.0%-9.0%
Debt to equity0.27
Interest cover5.0x
Current ratio1.36
P/E ratio24.5

4 · The owners

Who holds it, and are they adding?

Promoter holding69.16%

Down 0.22 pts over 8 quarters.

Foreign institutions0.93%

Down 1.04 pts over 8 quarters.

Domestic institutions3.06%

Down 0.41 pts over 8 quarters.

Mutual fund schemes12

+4 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter69.3869.3869.3769.3569.3569.3569.3469.16-0.22
FII1.972.481.631.61.61.150.690.93-1.04
DII3.473.384.053.23.393.823.833.06-0.41
Public25.1824.7624.9425.8525.6625.6826.1426.84+1.66

Mutual fund holdings · Oct 2026

12 schemes hold this stock

8 the month before.

  • ICICI Prudential Commodities Fund0.8% of NAV
  • ICICI Prudential Multi Cap Fund0.35% of NAV
  • Motilal Oswal Nifty Microcap 250 Index Fund0.16% of NAV
  • ICICI Prudential Multi Asset Allocation Fund0.03% of NAV
  • Bandhan Nifty Total Market Index Fund0.01% of NAV
  • Motilal Oswal BSE 1000 Index Fund0.01% of NAV
  • Groww Nifty Total Market Index Fund0.01% of NAV
  • Angel One Nifty Total Market ETF0.01% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for LXCHEM are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about LXCHEM

What is the LXCHEM share price?

LXCHEM (LXCHEM) last closed at ₹153.85, up 2.02% on the day. Its 52-week range is ₹108.11 to ₹200.51.

What is the market cap of LXCHEM?

LXCHEM has a market capitalisation of about ₹4,185 crore. Its price-to-earnings ratio is 24.5.

How are LXCHEM's latest results?

LXCHEM reported revenue of ₹1,083 crore for Sep 2026, up 54.7% from a year earlier. Net profit was ₹57 crore (up 418.2% year on year). Return on equity was 4.0% in Mar 2026. Promoter holding was 69.16% in Sep 2026, down 0.22 points over 8 quarters.

Who owns LXCHEM?

As of Sep 2026, shareholding was: Promoter 69.16%, FII 0.93%, DII 3.06%, Public 26.84%.

How many mutual funds hold LXCHEM?

12 mutual fund schemes held LXCHEM in October 2026. That compares with 8 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 18 Jul 2025 · Final Dividend - Rs. 0.5
  • 19 Jul 2024 · Final Dividend - Rs. 0.6
  • 21 Jul 2023 · Final Dividend - Rs. 0.5
  • 18 Jul 2022 · Final Dividend - Rs. 0.7
  • 14 Jul 2021 · Final Dividend - Rs. 0.5

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.